High detection rate of dog circovirus in diarrheal dogs
- Han-Siang Hsu†1,
- Ting-Han Lin†1,
- Hung-Yi Wu2,
- Lee-Shuan Lin1, 3,
- Cheng-Shu Chung1, 3,
- Ming-Tang Chiou1, 4Email author and
- Chao-Nan Lin1, 4Email authorView ORCID ID profile
© The Author(s). 2016
Received: 22 December 2015
Accepted: 3 June 2016
Published: 17 June 2016
Diarrhea is one of the most common clinical symptoms reported in companion animal clinics. Dog circovirus (DogCV) is a new mammalian circovirus that is considered to be a cause of alimentary syndromes such as diarrhea, vomiting and hemorrhagic enteritis. DogCV has previously only been identified in the United States, Italy, Germany (GeneBank accession number: KF887949) and China (GeneBank accession number: KT946839). Therefore, the aims of this study were to determine the prevalence of DogCV in Taiwan and to explore the correlation between diarrhea and DogCV infection. Clinical specimens were collected between 2012 and 2014 from 207 dogs suffering from diarrhea and 160 healthy dogs.
In this study, we developed a sensitive and specific SYBR Green-based real-time PCR assays to detected DogCV in naturally infected animals. Of the analyzed fecal samples from diarrheal dogs and health dogs, 58 (28.0 %) and 19 (11.9 %), respectively, were DogCV positive. The difference in DogCV prevalence was highly significant (P = 0.0002755) in diarrheal dogs.
This is the first study to reveal that DogCV is currently circulating in domestic dogs in Taiwan and to demonstrate its high detection rate in dogs with diarrhea.
Gastrointestinal disorders are one of the most common diseases reported in companion animal clinics. They can be caused by a number of viral, bacterial and parasitic pathogens. The most common viral gastrointestinal-pathogens are canine parvovirus [1, 2] and coronavirus. However, other agents, such as dog circovirus (DogCV), have recently been considered to be related to enteric disorders in dogs [3, 4]. DogCV was first identified in dogs with vasculitis and/or hemorrhagic gastroenteritis in the United States in 2012 . DogCV is a non-enveloped, circular, single-stranded DNA virus containing a circular genome approximately 2 kb in length. It belongs to the genus Circovirus, together with porcine circovirus type 1 (PCV1), porcine circovirus type 2 (PCV2), canary circovirus, beak and feather disease virus and other viruses of domestic and wild birds .
PCV2 causes clinical conditions including systemic, lung, enteric, reproductive and skin diseases . In recent years, a possible association between DogCV and canine enteritis has been suggested [3, 4]. DogCV has also been reported to cause necrotizing lymphadenitis  and vasculitis, which are also caused by porcine circovirus type 2 infections in pigs . Previous studies have shown that DogCV is associated with hemorrhagic enteritis in dogs [3, 4], however, limited information is available to determine the direct correlation between the severity of diarrhea and DogCV infections.
DogCV has only been detected in the US [4, 6], Italy , Germany (GeneBank accession number: KF887949) and China (GeneBank accession number: KT946839). In the present study, we determined the previously unidentified DogCV and its prevalence in Taiwanese household dogs and clarified the correlation between diarrhea and DogCV infection.
Ethics and consents
The study did not involve any animal experiment. The Institutional Animal Care and Use Committee (IACUC) of National Pingtung University of Science and Technology did not deem it necessary for this research group to obtain formal approval to conduct this study. The dog owners gave his/her written consent for sample collection and data publication. Besides, according to Dr. Baneux’ recommendations “Privately owned animals that are recruited for clinical studies (not Public Health Service funded) do not need to be subjected to IACUC oversight as long as their involvement includes only procedures that are consistent with the standard of care provided to patients with the same diagnosis that are not included in the clinical study” .
Specimen collection and DNA extraction
Clinical specimens, including rectal swabs or feces, were collected from dogs presenting at animal hospitals in Taiwan between June 2012 and June 2014. A total of 367 household dogs were enrolled in this study. These included 160 healthy dogs with no symptoms of diarrhea (for routine health check) and 207 dogs with diarrhea. The age, breed, sex of each dog and the date of sampling were recorded. The range of age span for dogs with and without diarrhea was from 2 months - 13 years old and 2.5 months - 18 years old, respectively. Fecal scores were determined and recorded according to the Waltham Fecal Scoring System. For detection of DogCV, fecal samples from these dogs with and without diarrhea were collected by inserting the swab into the rectum (~2 cm), rotating the swab and then placing the swab in the nuclease-free water. To ensure the diarrhea only results from DogCV infection, fecal samples taken from diarrheal dogs were also tested for CPV-2, CCV, giardia (CPV/CCV/Giardia Ag Test Kit, BIONOTE, Republic of Korea) and CDV (CDV Ag Test Kit, BIONOTE, Republic of Korea). All clinical specimens were sent to the animal disease diagnostic center at the National Pingtung University of Science and Technology. The weight of the stool sample was diluted 1:10 (w/v) with PBS, and vortexed for 5 min at maximum speed to generate a stool suspension. Viral DNA was extracted from clinical samples using the Genomic DNA Mini Kit (Geneaid Biotech, Ltd., Taipei, Taiwan) according to the manufacturer’s protocol. GAPDH was used for DNA quality control of all samples. All of specimens were screened using real-time PCR for CPV-2, as described by Lin et al  and for DogCV, as described below.
Primer design for DogCV
Construction of plasmid DNA standard curves
The oligonucleotide primers used for the amplification of PCV1, PCV2 and DogCV were Rep CircoV-F, 5’-TGG TGG GAY GGH TAY SAT GG-3’ and Rep CircoV-R, 5’-TAH CGR TCA CAB ART CTC A-3’; the sequences of these primers correspond to base pair positions 607-626 and 701-683, respectively, of DogCV strain NY214 (GenBank accession number JQ821932) . Using these primers, 95 bp fragments of the replicase gene were amplified from PCV1, PCV2 and DogCV. The PCR products were cloned using the TA cloning kit (Yeastern Biotech Co., Ltd. Taipei, Taiwan) and sequenced. The plasmids containing the circovirus sequences were purified using a plasmid miniprep purification kit (GMbiolab Co, Ltd. Taichung, Taiwan) and quantified by the measurement of optical density (OD) at 260 nm with a spectrophotometer (Hitachi U2900, Dallas, TX, USA). A standard curve was generated using 10-fold dilutions (102-108 copies/μl) of standard plasmid DNA to determine the detection limits of the SYBR Green-based real-time PCR assay. Intra- (within-run) and inter- (between-run) assay reproducibility was evaluated using the standard plasmid DNA in triplicate on three different days.
Real-time PCR for the detection of DogCV
SYBR Green-based real-time PCR assays were performed using a LightCycler Nano (Roche Diagnostics, Mannheim, Germany). Each 10-μl reaction mixture contained 0.2 μM of forward and reverse primers, 5 μl of Master buffer (Roche Diagnostics, Mannheim, Germany) and 3 μl of DNA extract. The thermocycling conditions consisted of 10 min at 95 °C, 45 cycles of 10 s each at 95 °C, 10 s at 51 °C and 10 s at 72 °C. Each run included serial 10-fold dilutions of the standard plasmid DNA as a positive control and for the construction of a standard curve. A negative control without the DNA template was included to detect possible cross-contamination.
Replicase gene sequencing and sequence analysis
The DNA fragments were purified and sequenced, as described by Lin et al . The partial replicase DNA sequence of our samples were compared to those of reference DogCV (JQ821392, NC020904, KC241983, KC241984, KF887949 and KJ530972), PCV1 (AY660574) and PCV2 (AY424401). Multiple alignments of the nucleic acid sequences were performed with the Clustal W method, using the MegAlign program (DNASTAR, Madison, WI).
The chi-square test with Yate’s correction was used to evaluate the correlation between the samples that were positive for DogCV and different clinical observation groups. The paired t-test was used to determine whether there is a statistically significant difference in age between diarrheal and healthy groups. A Wilcoxon Rank-Sum test was used to evaluate the correlation between the severity of diarrhea and samples positive for DogCV. Differences were considered to be statistically significant and highly significant if the associated P-value was <0.05 and <0.01, respectively.
Real-time PCR amplification efficiency and limits of detection
Efficiency of the Dog circovirus (DogCV) SYBR Green-based real-time PCR assay
Estimated number of DogCV plasmid DNA copies
Number of positive/number of tested
Mean Cq ± SD
14.64 ± 0.62
18.75 ± 0.83
23.06 ± 1.24
27.61 ± 1.53
32.11 ± 1.71
36.58 ± 2.28
40.19 ± 1.29
Overall detection of gastrointestinal pathogens using commercial kits and real-time PCR
Correlation between the severity of diarrhea and the different canine gastrointestinal pathogens
The Waltham fecal scoring system
DogCV + other pathogens
Other pathogens (without DogCV)
Correlation of diarrhea with positive test for DogCV
Correlation of diarrhea with dog circovirus (DogCV) infection
Results of DogCV detection
149 (51.4 %)
58 (75.3 %)
141 (48.6 %)
19 (24.7 %)
Correlation of age with positive test for DogCV
Of the 58 DogCV-positive dogs in diarrheal group, 25 (43.1 %) were less than 1 year old, 25 (43.1 %) were between 1-7 years old, and 8 (13.8 %) were more than 7 years old. The range of age spans for DogCV-positive dogs was from 2 months - 13 years old (median is 1 year old). Of 19 DogCV-positive dogs in the health group, 3 (15.8 %) were less than 1 year old, 8 (42.1 %) were between 1-7 years old, and 8 (42.1 %) were more than 7 years old. The range of age spans for DogCV-positive dog was from 3 months - 18 years old (median is 5 year old). By statistic analysis, it was found that there was a statistically significant difference in age between diarrheal and healthy groups with respect to the DogCV-positive dogs (P = 0.005). That is, the DogCV was more frequently identified from younger dogs in diarrheal group.
Genetic comparison of the DogCVs
Sequence homology between Taiwan and reference DogCVs
In the present study we determine the prevalence of DogCV in Taiwan. Besides, our results suggest that the positive test results for DogCV appear to have a highly significant correlation with the presence of diarrhea (P = 0.0002755) and that dogs with diarrhea were 3 times more likely to be DogCV-positive than those which are clinically healthy. In contrast, a study conducted in the US using real-time PCR reported that the difference in the prevalence of DogCV between healthy and diarrheal dogs was not significant . These differing results might be due to the following: i) geographic distribution, (i.e., USA vs. Taiwan); or ii) primer design (i.e., the specific primer for DogCV used in the previous study (Additional file 1: Figure S1) vs. the degenerate primer for mammal circovirus in our study). In the present study, we established a SYBR-Green-based PCR assay to detect DogCV. This novel, real-time PCR was specific, sensitive and reliable for the amplification of DogCV. Both intra- and inter-assay CVs were satisfactorily low.
Forty-three out of the 58 (74.1 %) DogCV-positive dogs were found to be positive for DogCV alone. The fecal scoring of those dogs was observed to range from “very moist stool” to “watery diarrhea”. This agrees with US and Italian studies, which showed a similar proportion of diarrheal dogs to be infected by DogCV alone [3, 4]. Diarrheal symptoms caused by circovirus have been observed in PCV2-associated enteritis . DogCV DNA has been detected in several lymphoid tissues, including Peyer’s patches and mesenteric lymph nodes . A moderate depletion of lymphocytes was found in DogCV-infected dogs, which might suggest immunosuppression in DogCV-affected dogs . However, the pathogenesis of DogCV infection remains to be elucidated.
A previous study reported that co-infection with other canine pathogens was found in DogCV-positive dogs with diarrhea . Co-infection with canine gastrointestinal pathogens was also observed in the present study. Surprisingly, twelve of the 15 DogCV-positive diarrheal dogs were also found to be CPV2-positive. Co-infection with DogCV and CPV-2 was not observed in the US or Italian studies [3, 4]. We further investigated the antigenic variants of CPV-2, and only CPV-2a or 2b were found in dogs co-infected with DogCV. This might be because no CPV-2c was found in Taiwan during the study period . In PCV2 infection, the expression of clinical disease in infected-pigs typically involves secondary microbial infections [9, 11]. Therefore, the role of co-infection in the pathogenesis of DogCV will require further investigation.
Our results showed that the partial replicase nucleotide sequences for local DogCV strains exhibited 91.6-93.7 % homology with those for Italian DogCV strain Bari/411-13. However, only a few complete genomes of DogCV are available in GeneBank. The patterns of the genetic evolution of DogCV need to be investigated through continuous surveillance and by analyzing the sequence of the complete genome.
This is the first study to reveal that DogCV is currently circulating in domestic dogs in Taiwan and to demonstrate its high detection rate in dogs with diarrhea.
CCV, canine coronavirus; CDV, canine distemper virus; CPV-2, canine parvovirus type 2; Cq, quantification cycles; DogCV, Dog circovirus (DogCV); OD: optical density; PCR, polymerase chain reaction; PCV1, porcine circovirus type 1; PCV2, porcine circovirus type 2; Tm, melting temperature.
The authors would like to thank Prof. Ling-Ling Chueh for comments that greatly improved the manuscript.
No funding was obtained for this study.
Availability of data and materials
All the data supporting our findings is contained within the manuscript.
HSH designed and analyzed the experiments and wrote the manuscript. THL designed and analyzed the experiments and wrote the manuscript. HYW performed and analyzed the experiments. LSL performed and analyzed the experiments. CSC performed and analyzed the experiments. MTC provided materials and reagents, analyzed and interpreted the data and drafted the manuscript. CNL provided materials and reagents, analyzed and interpreted the data and drafted the manuscript. All of the authors read and approved the final manuscript.
The authors declare that they have no competing interests.
Consent for publication
Ethics approval and consent to participate
The study did not involve any animal experiment. The Institutional Animal Care and Use Committee (IACUC) of National Pingtung University of Science and Technology did not deem it necessary for this research group to obtain formal approval to conduct this study.
The dog owners gave his/her written consent for sample collection and data publication.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Decaro N, Buonavoglia C. Canine parvovirus- a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Vet Microbiol. 2012;155(1):1–12.View ArticlePubMedGoogle Scholar
- Decaro N, Buonavoglia C. An update on canine coronaviruses: viral evolution and pathobiology. Vet Microbiol. 2008;132(3-4):221–34.View ArticlePubMedGoogle Scholar
- Decaro N, Martella V, Desario C, Lanave G, Circella E, Cavalli A, Elia G, Camero M, Buonavoglia C. Genomic characterization of a circovirus associated with fatal hemorrhagic enteritis in dog, Italy. PLoS One. 2014;9(8):e105909.View ArticlePubMedPubMed CentralGoogle Scholar
- Li L, McGraw S, Zhu K, Leutenegger CM, Marks SL, Kubiski S, Gaffney P, Dela Cruz FN, Jr., Wang C, Delwart E, et al. Circovirus in tissues of dogs with vasculitis and hemorrhage. Emerg Infect Dis. 2013;19(4):534–41.View ArticlePubMedPubMed CentralGoogle Scholar
- Segales J. Porcine circovirus type 2 (PCV2) infections: clinical signs, pathology and laboratory diagnosis. Virus Res. 2012;164(1-2):10–9.View ArticlePubMedGoogle Scholar
- Kapoor A, Dubovi EJ, Henriquez-Rivera JA, Lipkin WI. Complete genome sequence of the first canine circovirus. J Virol. 2012;86(12):7018.View ArticlePubMedPubMed CentralGoogle Scholar
- Baneux PJ, Martin ME, Allen MJ, Hallman TM. Issues related to institutional animal care and use committees and clinical trials using privately owned animals. ILAR J. 2014;55(1):200–9.View ArticlePubMedGoogle Scholar
- Lin CN, Chien CH, Chiou MT, Wang JW, Lin YL, Xu YM. Development of SYBR green-based real-time PCR for the detection of canine, feline and porcine parvoviruses. Taiwan Vet J. 2014;40(1):1–9.View ArticleGoogle Scholar
- Darwich L, Segales J, Mateu E. Pathogenesis of postweaning multisystemic wasting syndrome caused by Porcine circovirus 2: An immune riddle. Arch Virol. 2004;149(5):857–74.View ArticlePubMedGoogle Scholar
- Lin CN, Chien CH, Chiou MT, Chueh LL, Hung MY, Hsu HS. Genetic characterization of type 2a canine parvoviruses from Taiwan reveals the emergence of an Ile324 mutation in VP2. Virol J. 2014;11(1):39.View ArticlePubMedPubMed CentralGoogle Scholar
- Segales J, Mateu E. Immunosuppression as a feature of postweaning multisystemic wasting syndrome. Vet J. 2006;171(3):396–7.View ArticlePubMedGoogle Scholar